What We're Reading
Industry reads hand-picked by our editors
May 22, 2026
-
Politico Pro
FDA’s Makary-era review program will go on — for now
-
The Wall Street Journal
Popular Weight Loss Drugs May Have Surprising Side Effect: Stalling Cancer
-
The Washington Post
There is no Ebola vaccine for this outbreak and won’t be one soon. Here’s why.
May 21, 2026
-
The Wall Street Journal
Biotech Investors Are Tuning Out the MAHA Chaos
-
Reuters
US working with small biotech firm on experimental Ebola treatment, HHS official says
-
Bloomberg
FDA Plans Rare Advisory Hearing to Debate Moderna’s Flu Shot
-
Endpoints
Driven by GLP-1s, pharma’s relationship with consumers is starting to change
May 20, 2026
May 19, 2026
-
The Financial Times
Lethal Ebola virus outbreak triggers urgent international quest for vaccine
-
KFF Health News
Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs
-
Inside Precision Medicine
Reporter’s Notebook: The Day the Scientific Debate Died
May 18, 2026
May 15, 2026
-
Reuters
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug
-
KFF Health News
FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
-
The Wall Street Journal
The Cancer Test That Wall Street Is Betting On
May 14, 2026
-
Labiotech.eu
What investors now expect from AI biotech companies
-
Science
Most dementia patients have multiple brain diseases. How should they be treated?
-
European Medical Journal
US cancer centres inundated for new pancreatic cancer drug
